# EXAGEN INC.: Form D filings

EXAGEN INC., a biotechnology company in Vista, CA, filed 25 Form D notices with the SEC between 2009 and 2019. The latest, on February 1, 2019, reports $6.6 million sold of a $16 million offering to 4 investors.

Find out what EXAGEN INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20EXAGEN%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=EXAGEN%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fexagen-inc-1274737)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20EXAGEN%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=EXAGEN%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fexagen-inc-1274737)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1261 Liberty Way, Suite C, Vista, CA, 92081
- Phone: (760) 560-1501
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1274737

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 1, 2019 | New notice | $16,000,000 | $6,586,411 | $9,413,589 | 4 | Jan 2, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000156761919002115/0001567619-19-002115-index.htm) |
| May 18, 2017 | New notice | $13,179,796 | $3,749,993 | $9,429,803 | 4 | May 4, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036117021394/0001140361-17-021394-index.htm) |
| Apr 10, 2017 | New notice | $1,314,500 | $1,314,500 | $0 | 5 | Apr 6, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036117015405/0001140361-17-015405-index.htm) |
| Mar 9, 2017 | New notice | $1,453,000 | $1,453,000 | $0 | 4 | Feb 24, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036117011136/0001140361-17-011136-index.htm) |
| Feb 1, 2017 | New notice | $995,889 | $995,889 | $0 | 4 | Jan 27, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036117003883/0001140361-17-003883-index.htm) |
| Dec 19, 2016 | New notice | $995,889 | $995,889 | $0 | 4 | Dec 12, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036116090192/0001140361-16-090192-index.htm) |
| Nov 10, 2016 | New notice | $995,889 | $995,889 | $0 | 4 | Nov 7, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036116085750/0001140361-16-085750-index.htm) |
| Oct 11, 2016 | New notice | $995,889 | $995,889 | $0 | 4 | Oct 5, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036116082419/0001140361-16-082419-index.htm) |
| Aug 30, 2016 | New notice | $1,000,000 | $1,000,000 | $0 | 4 | Aug 26, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036116078129/0001140361-16-078129-index.htm) |
| Jun 24, 2016 | New notice | $2,100,000 | $2,100,000 | $0 | 6 | Jun 21, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036116070788/0001140361-16-070788-index.htm) |
| Jan 26, 2016 | New notice | $30,852,618 | $16,817,541 | $14,035,077 | 13 | Jan 19, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036116048645/0001140361-16-048645-index.htm) |
| Oct 21, 2015 | New notice | $4,500,000 | $2,999,766 | $1,500,234 | 4 | Oct 9, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036115038122/0001140361-15-038122-index.htm) |
| Jul 6, 2015 | New notice | $3,000,000 | $3,000,000 | $0 | 3 | Jul 2, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036115026680/0001140361-15-026680-index.htm) |
| Apr 1, 2015 | New notice | $4,547,811 | $1,818,767 | $2,729,044 | 8 | Feb 19, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036115013896/0001140361-15-013896-index.htm) |
| Jul 21, 2014 | New notice | $3,950,000 | $3,950,000 | $0 | 12 | Jul 10, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000114036114028869/0001140361-14-028869-index.htm) |
| Oct 15, 2013 | New notice | $5,016,977 | $5,016,977 | $0 | 11 | Oct 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465913075606/0001104659-13-075606-index.htm) |
| Nov 1, 2012 | New notice | $679,407 | $123,745 | $555,662 | 5 | Oct 18, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465912073261/0001104659-12-073261-index.htm) |
| Sep 11, 2012 | New notice | $5,306,834 | $5,306,834 | $0 | 7 | Sep 4, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465912062751/0001104659-12-062751-index.htm) |
| Dec 22, 2011 | New notice | $24,709,488 | $11,986,707 | $12,722,781 | 9 | Dec 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000121390011006808/0001213900-11-006808-index.htm) |
| Nov 18, 2011 | New notice | $1,000,000 | $1,000,000 | $0 | 4 | Nov 4, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000121390011006258/0001213900-11-006258-index.htm) |
| Sep 27, 2011 | New notice | $6,450,000 | $4,910,423 | $1,539,577 | 8 | Sep 13, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465911053475/0001104659-11-053475-index.htm) |
| Jun 29, 2011 | New notice | $5,799,998 | $4,910,490 | $889,508 | 8 | Jun 14, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465911037028/0001104659-11-037028-index.htm) |
| May 11, 2011 | Amendment | $5,427,984 | $5,427,984 | $0 | 17 | Oct 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465911028048/0001104659-11-028048-index.htm) |
| Oct 25, 2010 | New notice | $3,548,404 | $1,999,995 | $1,548,409 | 10 | Oct 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000110465910053490/0001104659-10-053490-index.htm) |
| May 26, 2009 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 15 | May 8, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1274737/000127473709000004/0001274737-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Daniel C. Burrell | Director |  |
| Thierry L.L. Dervieux | Executive Officer |  |
| Fortunato R. Rocca | Executive Officer, Director |  |
| Ebetuel R. Pallares | Director |  |
| James L.L. Tullis | Director |  |
| Kamal L.L. Adawi | Executive Officer |  |
| Arthur L.L. Weinstein | Director |  |
| Brian R. Birk | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Jan 28, 2019](https://specstream.ai/data/form-d/week/2019-01-28) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what EXAGEN INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).